Search results
Results From The WOW.Com Content Network
The Government Pharmaceutical Organization (GPO) (Thai: องค์การเภสัชกรรม; RTGS: Ongkan Phesatchakam) is a Thai state enterprise which manufactures pharmaceutical products in Thailand. In 2011, the GPO netted a profit of 1.6 billion baht from the sale of pharmaceuticals and medical equipment.
In 1993, President Bill Clinton signed the GPO Electronic Information Access Enhancement Act, which enabled GPO to put Government information online for the first time. [22] One year later, GPO began putting Government information online for the public to access. In 2009, GPO replaced its GPO Access website with the Federal Digital System, or ...
A GPO's earnings come from an "Administrative" fee. GPOs may collect an "Administrative" fee up to 3.0% of all sales volumes from the vendors that they negotiate a contract from, upon selling products to their member hospitals. These fees do not influence the prices negotiated. They are used to cover the GPO's operating expenses.
Johnson's original plan called for extending government spending at current levels until March and added other provisions like relief for disaster victims and farmers and a pay raise for members ...
Coco Gauff led the United States to its second United Cup title with a statement 6-4, 6-4 win over world No. 2 Iga Świątek a week before the start of the Australian Open. Gauff, the world No. 3 ...
Another pay increase of 4.5% was given to military members as part of the 2025 National Defense Authorization Act. Earlier this year, a pay raise of 5.2% on average was given to federal employees ...
By August 2014, MedAssets had become the largest GPO in the United States. [6] The company became publicly traded in 2007. [ 7 ] MedAssets expanded its services over time and offerings included cost and clinical resource management, purchasing and revenue cycle solutions, change management consulting, and data-driven analytic software.
When it comes to blockbuster weight-loss drugs like Wegovy and Ozempic, opinion among some of President-elect Donald Trump’s top advisers and health policy nominees appears deeply split.